RothwellPMCoullAJGilesMF. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet2004; 363:1925–33.
2.
BarberPAZhangJDemchukAM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology2001; 56:1015–20.
3.
JohnstonSCGressDRBrownerWS. Short-term prognosis after emergency department diagnosis of TIA. JAMA2000; 284:2901–6.
4.
ChenZMSandercockPPanHC. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke2000; 31:1240–9.
5.
RothwellPMEliasziwMGutnikovSA. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke2004; 35:2855–61.
6.
KennedyJEliasziwMHillM. The fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER) trial. Sem Cerebrovasc Dis Stroke2003; 3:1–6.
7.
RothwellPMGilesMFFlossmannE. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet2005; 366:29–36.
8.
EliasziwMKennedyJHillMD. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ2004; 170:1105–9.
9.
ValtonLLarrueVle TraonAP. Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke1998; 29:2125–8.
10.
MarkusHSMacKinnonA: Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke2005; 36:971–5.
11.
LeviCRRobertsAKFellG. Transcranial Doppler microembolus detection in the identification of patients at high risk of perioperative stroke. Eur J Vasc Endovasc Surg1997; 14:170–6.
12.
DouglasVCJohnstonCMElkinsJ. Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke2003; 34:2894–8.
13.
van EverdingenKJvan der GrondJKappelleLJ. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke1998; 29:1783–90.
14.
KidwellCSAlgerJRDi SalleF. Diffusion MRI in patients with transient ischemic attacks. Stroke1999; 30:1174–80.
15.
TakayamaHMiharaBKobayashiM. Usefulness of diffusion-weighted MRI in the diagnosis of transient ischemic attacks. No To Shinkei2000; 52:919–23.
16.
PurroyFMontanerJRoviraA. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke2004; 35:2313–9.
17.
CrisostomoRAGarciaMMTongDC: Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics. Stroke2003; 34:932–7.
18.
AyHOliveira-FilhoJBuonannoFS. ‘Footprints’ of transient ischemic attacks: a diffusion-weighted MRI study. Cerebrovasc Dis2002; 14:177–86.
19.
RoviraARovira-GolsAPedrazaS. Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks. Am J Neuroradiol2002; 23:77–83.
20.
InatomiYKimuraKYoneharaT. DWI abnormalities and clinical characteristics in TIA patients. Neurology2004; 62:376–80.
21.
CouttsSBSimonJEEliasziwM. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol2005; 57:848–54.
22.
CouttsSBHillMDSimonJE. Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology2005; 65:513–7.
23.
HandPJWardlawJMRowatAM. Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties. J Neurol Neurosurg Psychiatr2005; 76:1525–7.
24.
BarberPAHillMDEliasziwM. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry2005; 76:1528–33.
25.
DienerHCBogousslavskyJBrassLM. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet2004; 364:331–7.
26.
TopolEJEastonDHarringtonRA. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation2003; 108:399–406.
27.
RothwellPM: Lessons from MATCH for future randomised trials in secondary prevention of stroke. Lancet2004; 364:305–7.
28.
ImaizumiTHoritaY. Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. J Neurosurg2004; 101:915–20.
ForderJPMunzenmaierDHGreeneAS: Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat. Am J Physiol Heart Circ Physiol2005; 288:H1989–96.
31.
BristowMSSimonJEBrownRA. MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab2005; 25:1280–7.
